TumVol Cancer Research Results

TumVol, Tumor Volume: Click to Expand ⟱
Source:
Type:
Tumor Volume
Scientific Papers found: Click to Expand⟱
2498- FBZ,    Unexpected Antitumorigenic Effect of Fenbendazole when Combined with Supplementary Vitamins
- in-vivo, lymphoma, NA
eff↓, Synergy↑, TumVol↓, antiOx↑, Hif1a↓,
6911- FIS,    New Mitochondria-Targeted Fisetin Derivative Compromises Mitophagy and Limits Survival of Drug-Induced Senescent Breast Cancer Cells
- vitro+vivo, BC, NA
MMP↓, mt-ROS↑, Apoptosis↑, p‑AMPK↑, Akt↓, HSP90↓, PI3K↓, Akt↓, mTOR↓, TumCP↓, TumMeta↓, angioG↓, TumCD↑, selectivity↑, TumVol↓,
6901- FIS,    Fisetin induces G2/M phase arrest and caspase-mediated cleavage of p21Cip1 and p27Kip1 leading to apoptosis and tumor growth inhibition in HNSCC
- in-vivo, HNSCC, CAL33
TumCG↓, TumCD↑, selectivity↑, TumCCA↑, CDC25↓, CDK1↓, CycB/CCNB1↓, P53↑, DNAdam↑, Apoptosis↑, γH2AX↑, cl‑PARP↑, other↝, JNK↑, PI3K↓, Akt↓, ERK↓, EGFR↓, STAT3↓, TumAuto↑, Dose↝, TumVol↓, Ki-67↓, cl‑Casp3↑, P21↓, p27/CDKN1B↓,
6982- Form,    Formononetin: A Review of Its Anticancer Potentials and Mechanisms
- Review, Var, NA
AntiTum↑, Apoptosis↑, BAX↑, Bcl-2↓, Casp3↑, TumCCA↑, cycA1/CCNA1↓, CycB/CCNB1↓, cycD1/CCND1↓, TumCP↓, VEGF↓, FGF↓, MMP2↓, MMP9↓, Synergy↑, ChemoSen↑, chemoPv↑, p‑Akt↓, p‑STAT3↑, TumCMig↓, TumCI↓, TIMP1↑, TIMP2↑, PI3K↓, Akt↓, Dose↝, TumCG↓, TumW↓, TumVol↓, angioG↓, Casp3↑, Casp9↑, cl‑PARP↑, DNArepair↓, MMP↓, BAX↑, Bcl-2↓, DR5↑, ROS↑, eff↓, p‑ERK↓, PTEN↑, Hif1a↓, eff↑, Synergy↑, ChemoSen↑, HDAC↓, *BioAv↑, *Half-Life↝, *BioAv↝, *BioAv↑, *BioAv↑, *eff↑,
6972- Form,  PacT,    Formononetin ameliorates the drug resistance of Taxol resistant triple negative breast cancer by inhibiting autophagy
- in-vivo, BC, MDA-MB-231
AntiCan↑, miR-199↓, ChemoSen↑, TumVol↓, Dose↝, TumCG↓, TumCCA↑, Apoptosis↑, TumAuto↓, eff↓,
8590- FS,    The Effect of Flaxseed in Breast Cancer: A Literature Review
- Review, BC, NA
*BioAv↑, *antiOx↑, *TC↓, *cardioP↑, *Ingr↑, *Ingr↑, chemoP↑, ChemoSen↑, TumVol↓, TumCG↓, Risk↓, Risk↓, Ki-67↓, OS↑, TumMeta↓,
8597- FSO,    Chemopreventive effects of dietary flaxseed oil on colon tumor development
- in-vivo, CRC, NA
Dose↝, TumVol↓, AntiCan↑,
8608- FSO,  Cisplatin,    Flax seed oil reduced tumor growth, modulated immune responses and decreased HPV E6 and E7 oncoprotein expression in a murine model of ectopic cervical cancer
- in-vivo, Cerv, NA
TumVol↓, TumW↓, ChemoSen↑, *TAC↑, lipid-P↑, CD8+↑, IFN-γ↑, IL4↓, E6↓, E7↓, P53↑,
948- Fuc,    Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia
- vitro+vivo, Bladder, T24/HTB-9 - in-vitro, Nor, HUVECs
p‑PI3k/Akt/mTOR↓, p‑p70S6↓, p‑4E-BP1↓, angioG↓, Hif1a↓, VEGF↑, TumCG↓, TumVol↓, TumW↓, Iron∅, ROS↓,
7041- GA,    Gallic acid suppresses the progression of clear cell renal cell carcinoma through inducing autophagy via the PI3K/Akt/Atg16L1 signaling pathway
- vitro+vivo, RCC, 786-O - in-vitro, RCC, ACHN - in-vitro, Nor, HK-2
selectivity↑, TumCP↓, TumCMig↓, TumCI↓, TumCCA↑, TumVol↓, TumW↓, Ki-67↓, MMP9↓, TumAuto↑, LC3B-II↓, Beclin-1/ATG6↓, p62↑,
1065- GA,    Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression
- vitro+vivo, Pca, NA
tumCV↓, MMP↓, DNAdam↑, HDAC1↓, HDAC2↓, PCNA↓, cycD1/CCND1↓, cycE1↓, P21↑, TumVol↓,
826- GAR,    Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo
- vitro+vivo, HCC, HepG2 - vitro+vivo, Liver, HUH7
STAT3↓, TumCP↓, cycD1/CCND1↓, Bcl-2↓, Bcl-xL↓, Mcl-1↓, survivin↓, VEGF↓, TumCCA↑, TumVol↓,
6563- Ger,  5-FU,    Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts
- vitro+vivo, Colon, SW-620 - in-vitro, Colon, Caco-2
TS↓, TK1↓, ChemoSen↑, TumVol↓, OS↑,
7137- GI,    6-Shogaol from dried ginger inhibits growth of prostate cancer cells both in vitro and in vivo through inhibition of STAT3 and NF-κB signaling
- in-vitro, Pca, LNCaP - in-vitro, Pca, DU145 - in-vitro, Pca, PC3 - vitro+vivo, Pca, HMVP2
STAT3↓, TNF-α↓, NF-kB↓, cycD1/CCND1↓, survivin↓, cMyc↓, IL7↓, RANTES↓, BAX↑, Bcl-2↓, P21↑, p27/CDKN1B↑, SOCS1↑, IRF1↑, eff↑, TumVol↓, TumW↓, toxicity↓,
7245- Gink,    Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity
- vitro+vivo, Pca, DU145 - in-vitro, CRC, HCT116 - in-vitro, Nor, MCF10
STAT3↓, cycD1/CCND1↓, survivin↓, Bcl-2↓, Bcl-xL↓, TumCG↓, Dose↝, TumCCA↑, Apoptosis↑, TumVol↓, TumW↓,
7260- Gink,    Ginkgetin: A natural biflavone with versatile pharmacological activities
- Review, Var, NA - Review, Stroke, NA - Review, AD, NA
*AntiCan↑, *Inflam↓, *AntiBio↑, *neuroP↑, *TumCCA↑, Apoptosis↑, TumAuto↑, iNOS↓, COX2/PTGS2↓, PGE2↓, NF-kB↓, PLA2↓, *neuroP↑, *Stroke↓, *AntiFungal↓, *Bacteria↓, Bcl-xL↓, Bcl-2↓, Casp9↑, Casp3↑, cl‑PARP↑, IL6↓, STAT3↓, JAK1↓, survivin↓, COX2/PTGS2↓, IAP1↓, MMP2↓, MMP9↓, PTEN↑, SHP1↑, Synergy↑, TumVol↓, TumW↓, *toxicity↓, *ROS↓,
7262- Gink,    Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways
- in-vitro, Ovarian, A2780S - in-vitro, Ovarian, SKOV3
Dose↝, TumCP↓, Apoptosis↑, TumCMig↓, TumCI↓, TumVol↓, p‑STAT3↓, p‑ERK↓, IR↓,
7281- Gins,    Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell
- vitro+vivo, Lung, A549 - vitro+vivo, Lung, H23
PI3K↓, Akt↓, TumW↓, TumVol↓,
838- Gra,    Antiproliferative activity of aqueous leaf extract of Annona muricata L. on the prostate, BPH-1 cells, and some target genes
- in-vitro, Pca, BPH1
BAX↑, Bcl-2↓, TumVol↓,
7482- H2,    Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application
- Review, Var, NA - Review, IBD, NA - Review, Stroke, NA - Review, Sepsis, NA - Review, AD, NA
Dose↝, *Inflam↓, *IL1β↓, *IL6↓, *TNF-α↓, *neuroP↑, *mTOR↓, *IL10↑, *TGF-β↑, *Sepsis↓, *NRF2↑, *antiOx↑, *Catalase↑, *SOD↑, *GPx↑, *ROS↓, *HO-1↑, *PI3K↑, *Akt↑, *hepatoP↑, *MPO↓, *cardioP↑, CDK4↓, CDK6↑, CD47↓, PI3K↓, Akt↓, Hif1a↓, selectivity↑, *MMP↑, *ATP↑, *ER Stress↓, *CHOP/DDIT3↓, *Casp12↓, *GRP78/BiP↓, *p38↓, *p‑JNK↓, *LC3‑Ⅱ/LC3‑Ⅰ↑, *p‑eIF2α↓, *ATF4↓, *XBP-1↓, *Imm↑, *IFN-γ↓, *IL4↓, *GranB/GZMB↓, NK cell↑, radioP↑, *CD4+↑, CD8+↑, *Dose↝, *other↑, *Dose↝, *antiPs↑, *BioAv↝, *GutMicro↑, Dose↝, *IBI↑, TumCP↓, TumCI↓, TumCMig↓, CD8+↑, PGC-1α↑, Akt↓, SCD1↓, *MDA↓, Synergy↑, *APP↓, *BACE/β-secretase↓, *Aβ↓, *cognitive↑, *neuroP↑, NP/CIPN↓, *Stroke↓, *NLRP3↓, *ALAT↓, *AST↓, *LPS↓, *hepatoP↑, chemoP↑, *creat↓, *Urea↓, *RenoP↑, *eff↑, Apoptosis↑, XIAP↓, IAP2/BIRC3↓, TumVol↓, MALAT1↓, EZH2↓, miR-124-3p↓, eff↑, ChemoSen↑, *compII↑, *compIII↑, *LDL↓, *Obesity↓, QoL↑, PFS↑, *antiAll↑,
7489- H2,    Molecular Hydrogen in the Treatment of Respiratory Diseases
- Review, Asthma, NA
*antiOx↑, *Inflam↓, *Apoptosis↓, *Dose↓, *Dose↝, *eff↑, *ROS↓, *RNS↓, *NRF2↑, *HO-1↑, *Fenton↓, *NLRP3↓, *NADPH↓, *NOX4↓, *NOX↓, *MPO↓, *NF-kB↓, *TNF-α↓, *IL6↓, *IL1β↓, *HMGB1↓, *IL4↑, *IL10↑, *M2 MC↑, *Treg lymp↝, *Bcl-2↑, *Bcl-xL↑, *PI3K↑, *Akt↑, *JAK2↑, *STAT3↑, *Dose↑, *CD4+↑, *CD25+↑, *FOXP3↑, *MDA↓, *SOD↑, *Catalase↑, *Casp3↓, *Casp9↓, *TBARS↓, *SpO2↑, *VitE↓, *OS↑, *Weight↑, *DNAdam↓, *PGE2↓, *MCP1/CCL2↓, *lipid-P↓, *TumCP↓, *tumCV↓, *TumCMig↓, *TumCI↓, TumW↓, TumVol↓, selectivity↑, QoL↑, ChemoSen↑, chemoP↑, radioP↑, ROS↑, NLRP3↑, Casp3↑, VEGF↓, Wnt↓, β-catenin/ZEB1↓, *antiAll↑,
2522- H2,    A Systematic Review of Molecular Hydrogen Therapy in Cancer Management
- Review, Var, NA
chemoP↑, OS↑, QoL↑, TumVol↑, ROS↑, AntiTum↑, other↝,
2509- H2,    Hydrogen inhibits endometrial cancer growth via a ROS/NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway
- in-vitro, Endo, AN3CA - in-vivo, Endo, NA
selectivity↑, mt-ROS↑, ROS↑, TumW↓, GSDMD↑, Pyro↑, Dose↝, eff↓, TumVol↓,
2503- H2,    Brain Metastases Completely Disappear in Non-Small Cell Lung Cancer Using Hydrogen Gas Inhalation: A Case Report
- Case Report, Lung, NA
TumVol↓, OS↑, Dose↝, Dose↝, CEA↓, CA125↓, CYFRA21-1↓, SIRT1↓, COX2/PTGS2↓, IL1β↓, IL6↓, TNF-α↓, HMGB1↓, NF-kB↓, EP2↓,
3152- H2,  VitC,  Rad,    Hydrogen and Vitamin C Combination Therapy: A Novel Method of Radioprotection
- in-vitro, Nor, HUVECs - in-vivo, NA, NA
AntiTum↑, OS↑, QoL↑, TumVol↓, radioP↑, Dose↑, Dose↝, Synergy↑,
1637- HCA,  OLST,    Orlistat and Hydroxycitrate Ameliorate Colon Cancer in Rats: The Impact of Inflammatory Mediators
- in-vivo, Colon, NA
TumVol↓, OS↑, *IL6↓, *NF-kB↓, *eff↑, *Casp3↓, *TNF-α↓, *Catalase↑, *NO↓, *ROS↓, *Inflam↓, *Apoptosis↓,
7370- HibSad,    Hibiscus sabdariffa leaf induces apoptosis of human prostate cancer cells in vitro and in vivo
- vitro+vivo, Pca, LNCaP - in-vitro, Pca, PC3 - in-vitro, Pca, DU145
eff↑, Dose↝, Bcl-2↓, Mcl-1↓, BAX↑, Cyt‑c↑, FasL↑, eff↑, TumW↓, TumVol↓, other↝,
7354- HibSad,    Hibiscus sabdariffa Leaf Extract Inhibits Human Prostate Cancer Cell Invasion via Down-Regulation of Akt/NF-kB/MMP-9 Pathway
- vitro+vivo, Pca, LNCaP
MMP9↓, NF-kB↓, Akt↓, TumVol↓, PI3K↓, *antiOx↑, Dose↝,
2081- HNK,    Honokiol induces ferroptosis in colon cancer cells by regulating GPX4 activity
- in-vitro, Colon, RKO - in-vitro, Colon, HCT116 - in-vitro, Colon, SW48 - in-vitro, Colon, HT-29 - in-vitro, Colon, LS174T - in-vitro, Colon, HCT8 - in-vitro, Colon, SW480 - in-vivo, NA, NA
tumCV↓, ROS↑, Iron↑, GPx4↓, mtDam↑, Ferroptosis↑, TumVol↓, TumW↓,
2073- HNK,    Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo
- in-vitro, OS, U2OS - in-vivo, NA, NA
TumCD↑, TumAuto↑, Apoptosis↑, TumCCA↑, GRP78/BiP↑, ROS↑, eff↓, p‑ERK↑, selectivity↑, Ca+2↑, MMP↓, Casp3↑, Casp9↑, cl‑PARP↑, Bcl-2↓, Bcl-xL↓, survivin↓, LC3B-II↑, ATG5↑, TumVol↓, TumW↓, ER Stress↑,
5049- HPT,    Nanoparticle-based hyperthermia distinctly impacts production of ROS, expression of Ki-67, TOP2A, and TPX2, and induction of apoptosis in pancreatic cancer
- vitro+vivo, PC, Panc02 - vitro+vivo, PC, Bxpc-3
tumCV↓, proCasp↑, ROS↑, Ki-67↓, TOP2↓, TumVol↓,
7569- HYP,    Inhibitory effects of hyperoside on lung cancer by inducing apoptosis and suppressing inflammatory response via caspase-3 and NF-κB signaling pathway
- vitro+vivo, Lung, A549
TumCP↓, TumCMig↓, TumCI↓, Casp3↑, Apoptosis↑, NF-kB↓, TNF-α↓, IL6↓, IL1β↓, IL18↓, TumVol↓, TumW↓,
7550- HYP,    Hyperoside Induces Breast Cancer Cells Apoptosis via ROS-Mediated NF-κB Signaling Pathway
- in-vitro, BC, MCF7 - in-vitro, BC, 4T1
*Inflam↓, AntiCan↑, tumCV↓, TumCMig↓, Apoptosis↑, Bcl-2↓, XIAP↓, BAX↑, cl‑Casp3↑, ROS↓, NF-kB↓, TumVol↓,
7589- I3C,    Indole-3-carbinol inhibits cell proliferation and induces apoptosis in Hep-2 laryngeal cancer cells
- vitro+vivo, Laryn, HEp2
TumCP↓, Apoptosis↑, PI3K↓, Akt↓, GSK‐3β↓, TumVol↓, *toxicity↓,
7629- Ins,    Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol
- in-vivo, Lung, NA
AntiCan↑, TumVol↓, PI3K↓, IL6↓, p‑STAT3↓, chemoPv↑,
7635- Ins,    The Role of Inositols in Endocrine and Neuroendocrine Tumors
- Review, Thyroid, NA
*Dose↝, VEGF↓, Imm↑, NK cell↑, Synergy↑, PI3K↓, Akt↓, EMT↓, MAPK↓, Wnt↓, NF-kB↓, IRes↓, *ROS↓, TumVol↓, *TSHR↓,
7637- Ins,    Investigating the mechanism of inositol against paclitaxel chemoresistance on triple-negative breast cancer by using 7T multiparametric MRI and mitochondrial changes
- vitro+vivo, BC, 4T1
TumVol↓, Dose↝, *toxicity↓, AMPK↓, Ki-67↓,
7680- iod,  doxoR,    Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection
- vitro+vivo, BC, NA
antiNeop↑, antiOx↑, Dose↝, TumVol↓, PCNA↓, Weight↑, cardioP↑, ChemoSen↑,
7691- IP6,    Inositol Hexaphosphate Suppresses Growth and Induces Apoptosis in Prostate Carcinoma Cells in Culture and Nude Mouse Xenograft: PI3K-Akt Pathway as Potential Target
- vitro+vivo, Pca, PC3 - in-vitro, Pca, C4-2B
TumCP↓, Apoptosis↑, Casp3↑, cl‑PARP↑, Akt↓, PI3K↓, p‑GSK‐3β↓, cycD1/CCND1↓, TumVol↓, TumW↓, PCNA↓, angioG↓, CD31/PECAM-1↓, ILK↓, VEGF↓, eNOS↓, Hif1a↓,
9180- ITCs,  SFN,    Epigenetics/epigenomics and prevention of early stages of cancer by isothiocyanates Review
- Review, Var, NA
HDAC↓, DNMT1↓, DNMT3B↓, BioAv↑, chemoPv↑, NRF2↑, HO-1↑, NQO1↑, GSK‐3β↓, β-catenin/ZEB1↓, EMT↓, ac‑H3↑, ac‑H4↑, Wnt↓, HDAC3↓, p‑γH2AX↑, hTERT/TERT↓, NA↑, cMyc↓, HDAC2↓, HDAC3↓, KLF4↓, TumVol↓, Dose?,
8011- itraC,    Anti-proliferation of breast cancer cells with itraconazole: Hedgehog pathway inhibition induces apoptosis and autophagic cell death
- vitro+vivo, BC, MCF7 - vitro+vivo, BC, SkBr3
MMP↓, Bcl-2↓, Casp3↑, TumAuto↑, LC3II↑, p62↓, HH↓, Shh↓, Gli1↓, Apoptosis↑, TumVol↓, eff↑, TumCCA↑,
7986- itraC,    Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma
- Trial, BCC, NA
Dose↝, TumCP↓, HH↓, TumVol↓, SD↑,
7991- itraC,    A Phase II Trial of Perioperative Oral Itraconazole for the Management of Low-Risk Basal Cell Carcinoma
- Trial, BCC, NA
Smo↓, Dose↓, TumVol↓, Endoglin↓, angioG↓, toxicity↝, GLI3↓, toxicity↓,
7989- itraC,    Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung Cancer
- Trial, NSCLC, NA
Dose↝, TumVol↓, angioG↓, IL1β↓, GM-CSF↓, HH∅, BioAv↝, other↝,
8027- IVM,    Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin
- Review, Var, NA
*AntiP↑, TumCD↑, PAK1↑, TumAuto↑, Casp↑, ICD↑, TCF↝, Hippo↓, Akt↓, mTOR↓, angioG↓, CSCs↓, MMP↓, Cyt‑c↑, Apoptosis↑, BAX↑, P53↑, Bcl-2↓, cycE/CCNE↓, cycD1/CCND1↓, CDK2↓, CDK6↓, CDK4↓, YAP/TEAD↓, TFE3↑, mTORC1↓, mitResp↓, OCR↓, compI↓, MMP↓, ROS↑, SOD2↑, ATP↓, eff↓, mitA↓, P-gp/ABCB1↓, TumVol↓,
8026- IVM,  immuno,    Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer
- vitro+vivo, BC, 4T1
ICD↑, Imm↝, Synergy↑, TumVol↓,
8042- IVM,    Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug
- vitro+vivo, Var, NA
Dose↝, TumCD↑, eff↓, TumCCA↑, ChemoSen↑, tumCV↓, TumVol↓, TumW↓,
7892- IVT,    Isovitexin attenuates tumor growth in human colon cancer cells through the modulation of apoptosis and epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway
- in-vitro, Nor, HCEC 1CT - in-vivo, Colon, NA
TumCP↓, selectivity↑, TumCMig↓, TumCI↓, EMT↓, Apoptosis↑, p‑PI3K↓, p‑Akt↓, p‑mTOR↓, Bcl-2↓, BAX↑, Casp3↑, TumVol↓, TumW↓,
7963- JG,    Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines
- vitro+vivo, Pca, LNCaP - in-vitro, Pca, DU145
Pin1↓, TumCP↓, TumVol↓, other↝,
7964- JG,    Juglone and KPT6566 Suppress the Tumorigenic Potential of CD44+CD133+ Tumor-Initiating Caco-2 Cells In Vitro and In Vivo
- vitro+vivo, Colon, Caco-2
CSCs↓, TumVol↓, Pin1↓,

Showing Research Papers: 101 to 150 of 249
Prev Page 3 of 5 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 249

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 3,   Catalase↓, 2,   Catalase↑, 2,   Fenton↑, 2,   GCLM↓, 1,   GPx↑, 1,   GPx1↓, 1,   GPx4↓, 4,   GSH↓, 7,   GSH↑, 1,   GSH/GSSG↓, 1,   GSTs↓, 1,   H2O2↑, 1,   HO-1↓, 2,   HO-1↑, 1,   hyperG↓, 1,   Iron↑, 4,   Iron∅, 1,   i-Iron↑, 1,   lipid-P↑, 4,   MDA↓, 1,   MDA↑, 4,   MPO↓, 1,   NQO1↑, 1,   NRF2↓, 2,   NRF2↑, 1,   NRF2↝, 1,   RNS↑, 1,   ROS↓, 4,   ROS↑, 59,   ROS↝, 1,   mt-ROS↑, 3,   SOD↓, 2,   SOD↑, 2,   SOD2↓, 2,   SOD2↑, 2,   TAC↓, 1,   TrxR1↓, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↓, 2,   NCOA4↑, 1,   TfR1/CD71↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   CDC25↓, 3,   compI↓, 2,   ETC↓, 1,   HSP60/HSPD1↓, 2,   mitResp↓, 1,   mtDam↑, 3,   OCR↓, 2,   OCR↑, 2,   OXPHOS↑, 3,   mt-OXPHOS↑, 1,   PDH↑, 1,   PGC-1α↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   ACC↑, 1,   ALAT↓, 3,   ALAT↑, 1,   ALDOAiso2↓, 1,   AMPK↓, 1,   AMPK↑, 2,   p‑AMPK↑, 2,   ATP↓, 3,   ATP↝, 1,   DHA↑, 1,   ECAR↓, 1,   ENO1↓, 1,   GAPDH↓, 1,   GlucoseCon↓, 4,   Glycolysis↓, 12,   Glycolysis↑, 1,   GSK‐3β↓, 2,   GSK‐3β↑, 1,   p‑GSK‐3β↓, 1,   p‑GSK‐3β↑, 2,   HK2↓, 7,   HMG-CoA↓, 1,   lactateProd↓, 7,   LDHA↓, 2,   lipoGen↓, 1,   NAD↓, 1,   PDK1 / PDPK1↓, 1,   PDKs↓, 1,   PFK↓, 1,   PFK1↓, 1,   PGK1↓, 1,   PKM2↓, 6,   PLA2↓, 1,   Pyrim↓, 1,   SCD1↓, 1,   SIRT1↓, 1,   SIRT1↑, 1,   TS↓, 1,   Warburg↓, 4,  

Cell Death(tgid=5) ⓘ

AIF↑, 1,   Apoptosis?, 1,   Apoptosis↓, 1,   Apoptosis↑, 84,   mt-Apoptosis↑, 2,   ASK1↑, 1,   BAD↓, 1,   Bak↑, 1,   BAX↑, 31,   Bax:Bcl2↑, 7,   Bcl-2↓, 44,   Bcl-2↑, 1,   Bcl-xL↓, 13,   BIM↑, 2,   Casp↑, 7,   proCasp↑, 1,   Casp1↑, 1,   Casp12↑, 1,   Casp3?, 1,   Casp3↓, 1,   Casp3↑, 39,   cl‑Casp3↑, 17,   proCasp3↑, 1,   Casp7?, 1,   Casp7↑, 4,   cl‑Casp7↑, 2,   Casp8↑, 8,   cl‑Casp8↑, 4,   Casp9?, 1,   Casp9↑, 19,   cl‑Casp9↑, 5,   cFLIP↓, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 11,   DR5↑, 1,   Endon↑, 1,   FasL↑, 2,   Ferroptosis↓, 1,   Ferroptosis↑, 6,   GSDMD↑, 1,   GSDME↑, 1,   IAP1↓, 2,   IAP2/BIRC3↓, 1,   ICD↑, 2,   iNOS↓, 2,   Mcl-1↓, 6,   MDM2↓, 2,   necrosis↑, 3,   p38↑, 2,   p‑p38↑, 4,   Pyro↑, 2,   survivin↓, 20,   TRAIL↑, 1,   TumCD↑, 13,   XIAP↓, 10,   XIAP↑, 1,   YAP/TEAD↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 28,   Akt↑, 3,   p‑Akt↓, 9,   AMPKα↓, 1,   AMPKα↑, 1,   BRAF↓, 1,   DYRK1B↓, 1,   EGFR↓, 3,   ERK↓, 6,   p‑ERK↓, 7,   p‑ERK↑, 1,   GNAI1↓, 1,   HER2/EBBR2↓, 1,   Hippo↓, 1,   IGF-1R↓, 3,   IKKα↓, 1,   IKKα↑, 1,   p‑IKKα↓, 2,   ILK↓, 1,   IR↓, 1,   IκB↓, 1,   IκB↑, 1,   JAK1↓, 2,   JAK2↓, 5,   JNK↓, 1,   JNK↑, 3,   p‑JNK↑, 3,   LIFR/CD118↓, 1,   MAPK↓, 6,   MAPK↑, 1,   MEK↓, 1,   mTOR↓, 14,   mTOR↑, 3,   p‑mTOR↓, 3,   p‑p70S6↓, 1,   P70S6K↓, 1,   PI3K↓, 23,   PI3K↑, 2,   p‑PI3K↓, 1,   p‑PI3k/Akt/mTOR↓, 1,   PIK3CA↑, 1,   PKA↓, 2,   PKCδ↓, 1,   PTEN↓, 1,   PTEN↑, 3,   Raf↓, 1,   SHP1↑, 1,   c-Src↓, 1,   STAT↓, 1,   STAT3↓, 19,   p‑STAT3↓, 3,   p‑STAT3↑, 2,   i-STAT3↓, 1,   STAT4↑, 1,   STAT5↓, 2,   TK1↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↑, 1,   cMyc↓, 5,   DNMT1↓, 2,   DNMT3B↓, 1,   EZH2↓, 2,   FOXM1↓, 1,   FOXO1↑, 1,   FOXO3↑, 1,   ac‑H3↑, 2,   ac‑H4↑, 2,   HDAC↓, 7,   HDAC1↓, 2,   HDAC2↓, 3,   HDAC3↓, 3,   IRF1↑, 1,   KCNQ1OT1↓, 1,   KLF2↓, 1,   KLF4↓, 1,   KLF5↓, 1,   miR-107↑, 1,   miR-124-3p↓, 1,   miR-139-5p↑, 1,   miR-155↓, 1,   miR-199↓, 1,   miR-21↓, 1,   miR-224↓, 1,   miR-340↓, 1,   miR-34a↑, 1,   miR-375↑, 1,   miR-422a↑, 1,   miR-497↑, 1,   OCT4↓, 5,   other↓, 2,   other↝, 10,   SALL4↓, 1,   SD↑, 1,   SOX2↓, 2,   TFE3↑, 1,   tumCV↓, 32,   tumCV↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 2,   eIF2α↑, 1,   ER Stress↓, 1,   ER Stress↑, 3,   GRP78/BiP↑, 3,   HSP70/HSPA5↓, 3,   HSP70/HSPA5↑, 1,   HSP90↓, 3,   HTRA↓, 2,   PERK↑, 1,   Proteasome↓, 1,   PSMB5↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

APA↑, 1,   ATG5↑, 3,   ATG5↝, 1,   ATG7↑, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 2,   Beclin-1/ATG6⇅, 1,   Beclin-1/ATG6↝, 1,   p‑Beclin-1/ATG6↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3A↑, 1,   LC3B↑, 1,   LC3B-II↓, 1,   LC3B-II↑, 1,   LC3I↑, 1,   LC3II↑, 1,   lysoMP↓, 1,   lysoMP↑, 1,   p62↓, 3,   p62↑, 2,   TumAuto↓, 2,   TumAuto↑, 17,   TumAuto↝, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↑, 13,   DNArepair↓, 1,   hTERT/TERT↓, 3,   NKX3.1↓, 1,   P53↑, 22,   i-P53↓, 1,   PARP↓, 1,   PARP↑, 2,   cl‑PARP↑, 21,   PARP1↑, 1,   cl‑PARP1↑, 3,   PCNA↓, 10,   PCNA↝, 1,   Telomerase↓, 1,   TOP2↓, 2,   γH2AX↑, 4,   p‑γH2AX↑, 2,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 4,   CDK2↓, 6,   CDK4↓, 7,   CDK4↑, 2,   CDK6↓, 1,   CDK6↑, 3,   CDKN1C/p57↑, 1,   Cyc↓, 2,   cycA1/CCNA1↓, 4,   CycB/CCNB1↓, 6,   cycD1/CCND1↓, 24,   cycD1/CCND1↑, 1,   cycE/CCNE↓, 3,   cycE1↓, 1,   E2Fs↓, 2,   FBXO5/EMI1↓, 1,   Ki-67↓, 23,   mitA↓, 1,   mitA↑, 2,   P21↓, 2,   P21↑, 15,   p27/CDKN1B↓, 1,   p27/CDKN1B↑, 4,   TubPol↓, 1,   TumCCA↑, 54,   UBE2C↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   ALDH↓, 4,   AXIN1↑, 1,   CD133↓, 2,   CD24↓, 1,   CSCs↓, 11,   CSCsMark↓, 1,   Diff↑, 1,   EP2↓, 1,   FGF↓, 2,   Gli1↓, 3,   HH↓, 4,   HH∅, 1,   IGF-1↓, 6,   Ki-67↓, 23,   LGR5↓, 1,   LRP6↓, 1,   p‑LRP6↓, 1,   mTORC1↓, 2,   Nanog↓, 2,   NOTCH↓, 1,   NOTCH1↓, 2,   NOTCH3↓, 1,   PTCH2↓, 1,   SCF↓, 1,   Shh↓, 3,   Smo↓, 1,   TumCG?, 1,   TumCG↓, 38,   TumCP↓, 59,   TumCP↑, 1,   WDR72↓, 1,   Wnt↓, 6,   Wnt/(β-catenin)↓, 2,  

Migration(tgid=13) ⓘ

ANGPT2↓, 1,   AP-1↓, 2,   Ca+2↓, 1,   Ca+2↑, 9,   Ca+2↝, 1,   CAFs/TAFs↓, 1,   Cdc42↓, 1,   Cdc42↑, 1,   COL1↓, 1,   E-cadherin↑, 10,   EMT↓, 17,   EpCAM↓, 2,   F-actin↓, 1,   p‑FAK↓, 1,   GLI3↓, 1,   hnRNPA1↓, 1,   ITGB4↓, 1,   MALAT1↓, 1,   MMP1↓, 1,   MMP16↓, 1,   MMP2↓, 15,   MMP3↓, 2,   MMP7↓, 2,   MMP9↓, 20,   MMPs↓, 3,   MUC1-C↓, 1,   MUC4↓, 1,   N-cadherin↓, 7,   PAI-1/SERPINE1↑, 1,   PAK1↑, 1,   Rho↓, 1,   serineP↓, 1,   Slug↓, 2,   p‑SMAD2↓, 1,   p‑SMAD3↓, 1,   Snail↓, 4,   TGF-β↓, 3,   TGF-β↑, 1,   TIMP1↓, 1,   TIMP1↑, 2,   TIMP2↑, 5,   TumCI↓, 26,   TumCMig↓, 38,   TumMeta?, 1,   TumMeta↓, 28,   Twist↓, 2,   uPA↓, 2,   Vim↓, 5,   Zeb1↓, 1,   α-SMA↓, 1,   α-SMA↑, 1,   β-catenin/ZEB1↓, 8,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 28,   CD31/PECAM-1↓, 3,   Endoglin↓, 1,   eNOS↓, 1,   HIF-1↓, 1,   Hif1a↓, 14,   NO↓, 1,   NO↑, 1,   VCAM-1↓, 2,   VEGF↓, 22,   VEGF↑, 1,   VEGFR2/KDR/Flk1↓, 2,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 3,   CellMemb↑, 1,   CLDN1↓, 1,   EPR↓, 1,   EPR↑, 4,   GLUT1↓, 3,   GLUT2↓, 1,   GLUT3↓, 1,   GLUT4↓, 1,   IBI↑, 1,   LAT↓, 1,   MMP↓, 23,   MMP↑, 1,   MPT↑, 1,   SLC12A5↓, 1,   SVCT-2↝, 1,   TRPM7↓, 1,   VGSC↑, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD44↓, 5,   CD47↓, 1,   CD8+↑, 3,   COX2/PTGS2↓, 16,   COX2/PTGS2↑, 1,   CXCR4↓, 2,   Gal-3↓, 1,   GM-CSF↓, 1,   HMGB1↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 1,   IFN-γ↑, 2,   IL1↑, 1,   IL10↓, 1,   IL18↓, 1,   IL1β↓, 8,   IL1β↑, 1,   IL4↓, 2,   IL6↓, 12,   IL7↓, 1,   IL8↓, 3,   Imm↑, 4,   Imm↝, 2,   Inflam↓, 4,   Macrophages↓, 1,   Neut↓, 1,   NF-kB↓, 31,   NF-kB↑, 1,   NK cell↑, 3,   NLRP3↑, 1,   p65↓, 4,   p‑p65↓, 3,   PD-L1↓, 1,   PD-L1↑, 2,   PGE1↓, 1,   PGE2↓, 2,   PSA↓, 8,   RANTES↓, 1,   SOCS1↑, 1,   T-Cell↑, 1,   TCF↝, 1,   TLR4↓, 1,   TNF-α↓, 8,   TNF-α↑, 2,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 1,   pH↑, 1,   pH∅, 1,   e-pH↓, 1,   e-pH↑, 1,   i-pH↓, 1,   Temp∅, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

ChE↓, 1,   SYN1↑, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↑, 1,   AR↓, 5,   AR-FL↓, 1,   AR-V7↑, 1,   CYP19↓, 1,   ER(estro)↓, 1,   Estro↝, 1,   FKBP5↓, 1,   PPARγ↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 9,   BioAv↑, 8,   BioAv↝, 4,   BioEnh↑, 2,   ChemoSen?, 2,   ChemoSen↑, 37,   ChemoSen⇅, 1,   CompStab↓, 1,   Dose?, 3,   Dose↓, 1,   Dose↑, 2,   Dose↝, 66,   Dose∅, 5,   eff↓, 27,   eff↑, 39,   eff↝, 6,   eff∅, 3,   GSTA1↓, 1,   GSTZ1↓, 1,   Half-Life↓, 3,   Half-Life↑, 1,   Half-Life↝, 2,   MDR1↓, 1,   P-gp/ABCB1↓, 2,   RadioS?, 1,   RadioS↑, 5,   RadioS↝, 1,   selectivity↑, 39,   Synergy↑, 29,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 3,   ALAT↓, 3,   ALAT↑, 1,   ALB↑, 1,   ALP↑, 1,   AR↓, 5,   ascitic↓, 1,   AST↓, 2,   AST↑, 1,   BG↓, 1,   BRAF↓, 1,   BUN↓, 1,   CA125↓, 1,   CEA↓, 1,   CYFRA21-1↓, 1,   E6↓, 1,   E7↓, 1,   EGFR↓, 3,   EZH2↓, 2,   FOXM1↓, 1,   HER2/EBBR2↓, 1,   hTERT/TERT↓, 3,   IL6↓, 12,   IRes↓, 1,   LDH↓, 1,   LDH↑, 2,   PD-L1↓, 1,   PD-L1↑, 2,   PSA↓, 8,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 15,   antiNeop↑, 1,   AntiTum↑, 9,   cardioP↑, 4,   chemoP↑, 12,   chemoPv↑, 4,   cognitive↑, 1,   fatigue↓, 2,   hepatoP↑, 4,   motorD↑, 1,   Mucositis↓, 1,   neuroP↑, 2,   NP/CIPN↓, 1,   OS↑, 33,   PFS↑, 1,   Pin1↓, 2,   QoL↑, 9,   radioP↑, 7,   Remission↑, 3,   Risk↓, 8,   Sleep↑, 1,   toxicity↓, 20,   toxicity↝, 2,   toxicity∅, 1,   TumNum↓, 2,   TumVol?, 1,   TumVol↓, 244,   TumVol↑, 3,   TumVol⇅, 1,   TumVol∅, 1,   TumW↓, 60,   TumW⇅, 1,   TumW∅, 1,   Weight↓, 2,   Weight↑, 7,   Weight∅, 3,  

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 1,   GutMicro↑, 3,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 1,   Ingr↝, 3,  
Total Targets: 605

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 10,   Catalase↑, 8,   Fenton↓, 1,   GPx↑, 4,   GPx1↑, 1,   GSH↑, 2,   GSR↑, 1,   GSTs↑, 3,   HDL↑, 1,   HO-1↑, 3,   lipid-P↓, 4,   MDA↓, 4,   MPO↓, 2,   NOX↓, 1,   NOX4↓, 1,   NRF2↑, 4,   RNS↓, 1,   ROS↓, 14,   ROS∅, 1,   SAM-e↑, 1,   SOD↑, 6,   SOD1↑, 1,   TAC↑, 1,   TBARS↓, 1,   VitE↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compII↑, 1,   compIII↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 1,   adiP↑, 1,   ALAT↓, 2,   ATP↑, 1,   ATP↝, 1,   FASN↓, 1,   glucose↓, 1,   LDL↓, 1,   NAD↝, 1,   NADPH↓, 1,   NH3↓, 1,   SREBP1/SREBF1↓, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 2,   Bcl-2↑, 1,   Bcl-xL↑, 1,   Casp12↓, 1,   Casp3↓, 3,   Casp8↓, 1,   Casp9↓, 2,   GranB/GZMB↓, 1,   p38↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   Akt↑, 2,   CREB↑, 1,   ERK↓, 1,   IκB↓, 1,   JAK2↑, 1,   p‑JNK↓, 1,   MAPK↓, 2,   mTOR↓, 1,   PI3K↑, 2,   PTEN↑, 1,   STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↓, 2,   HDAC↓, 1,   other↑, 1,   tumCV↓, 2,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 2,   p‑eIF2α↓, 1,   ER Stress↓, 2,   GRP78/BiP↓, 2,   PERK↓, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

LC3‑Ⅱ/LC3‑Ⅰ↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

BMPs↑, 1,   IGF-1↓, 1,   TumCP↓, 1,  

Migration(tgid=13) ⓘ

Ca+2↝, 1,   serineP↓, 1,   TGF-β↑, 1,   TumCI↓, 1,   TumCMig↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

Endoglin↑, 1,   p‑eNOS↑, 1,   Hif1a↑, 1,   NO↓, 2,   VEGF↑, 2,  

Barriers & Transport(tgid=15) ⓘ

IBI↑, 1,   MMP↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD25+↑, 1,   CD4+↑, 2,   COX2/PTGS2↓, 3,   FOXP3↑, 1,   HMGB1↓, 1,   IFN-γ↓, 1,   IL10↓, 1,   IL10↑, 2,   IL1β↓, 2,   IL4↓, 1,   IL4↑, 1,   IL6↓, 5,   Imm↑, 1,   Inflam↓, 12,   LPS↓, 1,   M2 MC↑, 1,   MCP1/CCL2↓, 1,   NF-kB↓, 6,   NLRP3↓, 2,   PGE2↓, 2,   TNF-α↓, 6,   Treg lymp↝, 1,   VitD↑, 2,  

Synaptic & Neurotransmission(tgid=18) ⓘ

BDNF↑, 2,   PSD95↑, 1,  

Protein Aggregation(tgid=19) ⓘ

APP↓, 1,   Aβ↓, 2,   BACE/β-secretase↓, 1,   β-Amyloid↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

END↑, 1,   FGF21↑, 1,   testos↑, 1,   TSHR↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 1,   BioAv↑, 7,   BioAv↝, 3,   Dose↓, 1,   Dose↑, 2,   Dose↝, 5,   eff↑, 5,   Half-Life↝, 2,   P450↓, 1,   selectivity↑, 1,   Synergy↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   AST↓, 2,   BMD↑, 1,   Calcium↑, 2,   CEA↓, 2,   creat↓, 2,   hs-CRP↓, 1,   IL6↓, 5,   LDH↓, 1,   Mag↑, 2,   SpO2↑, 1,   TC↓, 1,   Urea↓, 1,   VitD↑, 2,  

Functional Outcomes(tgid=23) ⓘ

antiAll↑, 2,   AntiCan↑, 2,   AntiDiabetic↑, 1,   antiPs↑, 1,   cardioP↑, 5,   chemoP↑, 1,   chemoPv↑, 1,   ChemoSideEff↓, 1,   cognitive↑, 5,   hepatoP↑, 2,   memory↓, 1,   memory↑, 3,   motorD↓, 1,   neuroP↑, 9,   Obesity↓, 3,   OS↑, 2,   RenoP↑, 2,   Risk↓, 1,   Stroke↓, 2,   toxicity↓, 12,   toxicity↝, 4,   toxicity∅, 7,   Weight↑, 1,   Weight∅, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiFungal↓, 1,   AntiFungal↑, 1,   AntiP↑, 1,   AntiViral↑, 1,   Bacteria↓, 3,   GutMicro↑, 3,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 2,  
Total Targets: 180

Scientific Paper Hit Count for: TumVol, Tumor Volume
16 Magnetic Fields
9 Silver-NanoParticles
9 doxorubicin
9 Magnetic Field Rotating
8 Curcumin
7 Quercetin
6 Hydrogen Gas
5 Apigenin (mainly Parsley)
5 Boron
5 EGCG (Epigallocatechin Gallate)
4 itraconazole
4 immunotherapy
4 Melatonin
4 Shikonin
4 Thymoquinone
3 Photodynamic Therapy
3 Vitamin C (Ascorbic Acid)
3 Ashwagandha(Withaferin A)
3 Betulinic acid
3 Radiotherapy/Radiation
3 Cisplatin
3 Dichloroacetate
3 5-fluorouracil
3 Evodiamine
3 Fenbendazole
3 Ginkgetin
3 Inositol
3 Ivermectin
3 mebendazole
3 MCT, metronomic chemo
3 Silymarin (Milk Thistle) silibinin
2 cetuximab
2 EMF
2 Gold NanoParticles
2 Allyl isothiocyanate
2 Allicin (mainly Garlic)
2 Baicalein
2 Berbamine
2 Berberine
2 Beta-Caryophyllene
2 Caffeic acid
2 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
2 Centella asiatica / Gotu kola → asiaticoside
2 Chlorogenic acid
2 Chrysin
2 Chemotherapy
2 Eugenol
2 Fisetin
2 Formononetin
2 Flaxseed Oil
2 Gallic acid
2 Orlistat
2 Hibiscus sabdariffa
2 Honokiol
2 Hyperoside
2 Sulforaphane (mainly Broccoli)
2 Juglone
2 Kaempferol
2 L-Theanine
2 Licochalcone A
2 SDG/lignans
2 Luteolin
2 capecitabine
2 Mangiferin
2 Methylsulfonylmethane
2 Mushroom Chaga, Inonotus obliquus
2 Naringin
2 Terpinen-4-ol / Tea Tree Oil
2 Aflavin-3,3′-digallate
1 1,8-Cineole
1 3-bromopyruvate
1 Açaí, Euterpe oleracea
1 chemodynamic therapy
1 wortmannin
1 Ajoene (compound of Garlic)
1 Alpha-Lipoic-Acid
1 low dose naltrexone
1 Artemisinin
1 Benzyl isothiocyanate
1 Brucea javanica
1 Bromelain
1 borneol
1 Vitamin D3
1 Boswellia (frankincense)
1 Black Rice, Oryza sativa
1 α-Bisabolol / Chamomile oil
1 Caffeine
1 Zinc
1 Capsaicin
1 Carvacrol
1 Cannabidiol
1 Celastrol
1 chaetocin
1 chitosan
1 Cucurbitacin
1 Oxaliplatin
1 Chlorella (Chlorella vulgaris)
1 SonoDynamic Therapy UltraSound
1 Cynaropicrin
1 Metformin
1 Bortezomib
1 Deguelin
1 diet FMD Fasting Mimicking Diet
1 diet Methionine-Restricted Diet
1 Diindolylmethane
1 Dandelion Root
1 Ginkgo biloba-EGb 761
1 Docetaxel
1 Emodin
1 Tetrahydroxystilbene glucoside
1 Electrical Pulses
1 Ferulic acid
1 Paclitaxel/Taxol
1 Flaxseed/Linseed
1 Fucoidan
1 Garcinol
1 Geraniol
1 Ginger/6-Shogaol/Gingerol
1 Ginseng
1 Graviola
1 HydroxyCitric Acid
1 Hyperthermia
1 Indole-3-carbinol
1 iodine
1 phytic acid, Inositol hexakisphosphate
1 Isothiocyanates
1 Isovitexin
1 Lasiodin
1 Licorice
1 Lemongrass Extract/Citral
1 Lycopene
1 Magnolol
1 Matrine
1 Modified Citrus Pectin
1 methylseleninic acid
1 Lemon Balm/Melissa officinalis
1 Morin
1 tamoxifen
1 Mistletoe/Viscum album Extracts
1 Helleborus niger extracts – Christmas Rose
1 Mushroom Lion’s Mane, Hericium erinaceus
1 Bicarbonate(Sodium)
1 Patchouli Oil (Pogostemon cablin)
1 Phenylbutyrate
1 Phycocyanin
1 Piperine
1 probiotics
1 Pterostilbene
1 enzalutamide
1 Resveratrol
1 Rutin
1 salinomycin
1 α-Santalol/Sandalwood oil
1 Selenium
1 Oxygen, Hyperbaric
1 Sesamin
1 Iron
1 Salvia miltiorrhiza
1 Thymol-Thymus vulgaris
1 Magnesium
1 Vitamin K2
1 Walnut
1 Xylitol
1 Zerumbone
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:530  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page